ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 687015 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 687015; 2) Community: the network communities that were significantly associated with the response to NSC 687015; 3) Molecule: the relationships between components within communities and NSC 687015; 4) MDR: the compounds that were significantly associated with the NSC 687015.

NSC Compound Enrichment Correlation
NSC 710716 Null 0.0282295482823984 0.1779841
NSC 721049 7Z-Plakortide H 0.0282295482823984 0.22764484
NSC 730868 (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one 0.0282295482823984 0.28173772
NSC 736802 Null 0.0282295482823984 0.36380719
NSC 740 Methotrexate 0.0282295482823984 0.4021434
NSC 744063 Null 0.0282295482823984 0.41972066
NSC 751152 3-(6/7-trifluoro-3-methyl-1,4-dioxy-quinoxaline-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone 0.0282295482823984 0.15456847
NSC 753769 Null 0.0282295482823984 -0.022083807
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0282295482823984 0.2223392
NSC 84074 Phosphonium, (3-bromopropyl)triphenyl- bromide 0.0282295482823984 0.30109124
Total:102  Current:67    [First] [Prev] [Next] [Last]